中药治疗肝豆状核变性:系统评价与Meta分析
Wilson's disease (WD) is a rare autosomal recessive inherited disorder of chronic copper toxicosis. Currently, Chinese herbal medicines (CHM) is widely used for WD.…
要点
- 中药辅助治疗可增加WD患者24小时尿铜排泄并改善肝功能。
- 中药可提高WD临床总有效率,且耐受性良好。
- 因方法学缺陷和中药异质性,证据有限,不推荐中药单药治疗WD。
核心结论
- 中药辅助治疗可用于肝豆状核变性患者,但证据有限,不能推荐作为单药治疗。
主要发现
- 与对照相比,中药显著增加24小时尿铜排泄(p<0.05)。
- 中药显著改善肝功能(p<0.05)。
- 中药显著提高临床总有效率(p<0.05)。
- 中药在WD患者中耐受性良好。
- 机制涉及逆转ATP7B突变、抗氧化、抗炎和抗肝纤维化。
关键数值与推荐
- 研究质量评分为2/7至4/7分(Cochrane协作工具7项标准)。
- 纳入标准为比较中药与西药常规或安慰剂的RCT。
临床怎么用
- 可考虑将中药作为WD的辅助治疗,但不应替代常规西药。
- 使用中药时需关注患者耐受性。
局限性
- 方法学存在缺陷,研究质量评分较低(2/7至4/7分)。
- 中药异质性较大,影响结果解释。
- 证据支持程度有限,需进一步开展针对个体中药方剂的严格RCT。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Wilson's disease (WD) is a rare autosomal recessive inherited disorder of chronic copper toxicosis. Currently, Chinese herbal medicines (CHM) is widely used for WD. Here, we conducted an updated systematic review to investigate the efficacy and safety of CHM for WD and its possible mechanisms. Randomized-controlled clinical trials (RCTs), which compared CHM with Western conventional medicine or placebo for WD, were searched in six databases from inception to July 2017. The methodological quality was assessed using 7-item criteria from the Cochrane's collaboration tool. All the data were analyzed using Rev-Man 5.3 software. Eighteen studies involving 1,220 patients were identified for the final analyses. A score of study quality ranged from 2/7 to 4/7 points. Meta-analyses showed that CHM could significantly increase 24-h urinary copper excretion and improve liver function and the total clinical efficacy rate for WD compared with control (p < 0.05). Additionally, CHM was well tolerated in patients with WD. The underlying mechanisms of CHM for WD are associated with reversing the ATP7B mutants, exerting anti-oxidation, anti-inflammation, and anti-hepatic fibrosis effects. In conclusion, despite the apparent positive results, the present evidence supports, to a limited extent because of the methodological flaws and CHM heterogeneity, that CHM paratherapy can be used for patients with WD but could not be recommended as monotherapy in WD. Further rigorous RCTs focusing on individual CHM formula for WD are warranted.
引用
- Xu MB, Rong PQ, Jin TY, et al. Chinese Herbal Medicine for Wilson's Disease: A Systematic Review and Meta-Analysis. Front Pharmacol. 2019. PMID: 31001112. doi:10.3389/fphar.2019.00277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。